Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation

Cancers
Maximiliano ArceGareth I Owen

Abstract

Hypercoagulable state is linked to cancer progression; however, the precise role of the coagulation cascade is poorly described. Herein, we examined the contribution of a hypercoagulative state through the administration of intravenous Coagulation Factor Xa (FXa), on the growth of solid human tumors and the experimental metastasis of the B16F10 melanoma in mouse models. FXa increased solid tumor volume and lung, liver, kidney and lymph node metastasis of tail-vein injected B16F10 cells. Concentrating on the metastasis model, upon coadministration of the anticoagulant Dalteparin, lung metastasis was significantly reduced, and no metastasis was observed in other organs. FXa did not directly alter proliferation, migration or invasion of cancer cells in vitro. Alternatively, FXa upon endothelial cells promoted cytoskeleton contraction, disrupted membrane VE-Cadherin pattern, heightened endothelial-hyperpermeability, increased inflammatory adhesion molecules and enhanced B16F10 adhesion under flow conditions. Microarray analysis of endothelial cells treated with FXa demonstrated elevated expression of inflammatory transcripts. Accordingly, FXa treatment increased immune cell infiltration in mouse lungs, an effect reduced by daltepar...Continue Reading

References

Mar 1, 1992·Journal of Applied Physiology·C E PattersonJ G Garcia
Aug 19, 2000·Circulation Research·G P van Nieuw AmerongenV W van Hinsbergh
May 23, 2001·Trends in Cardiovascular Medicine·A R Rezaie
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Dec 20, 2005·Journal of Thrombosis and Haemostasis : JTH·C FeistritzerM Riewald
Jan 4, 2006·Thrombosis Research·Tufia C Haddad, Edward W Greeno
Sep 26, 2007·Nature Reviews. Immunology·Jordan S Pober, William C Sessa
Nov 21, 2007·Thrombosis Research·Maria Grazia Lampugnani, Elisabetta Dejana
Dec 29, 2007·Cancer Treatment Reviews·Kathleen DassFazlul H Sarkar
Dec 29, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Dietmar Vestweber
Apr 19, 2008·The International Journal of Biochemistry & Cell Biology·Malvina A KrupiczojcRachel C Chambers
Jan 30, 2009·Pathophysiology of Haemostasis and Thrombosis·Grigoris T GerotziafasIsmail Elalamy
Mar 25, 2009·Nature Reviews. Cancer·Don X NguyenJoan Massagué
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Raj S KasthuriNigel Mackman
Mar 30, 2010·Thrombosis Research·Keren BorensztajnC Arnold Spek
Apr 23, 2010·British Journal of Cancer·S Noble, J Pasi
Jul 16, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·A SparsaJ-M Bonnetblanc
Jan 7, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Heinz Läubli, Lubor Borsig
Oct 20, 2011·Cancer Research·Maya ZiglerMenashe Bar-Eli
Apr 17, 2012·International Journal of Cell Biology·Gerd Bendas, Lubor Borsig
Jul 4, 2012·Proceedings of the National Academy of Sciences of the United States of America·Matías A BustosClaudia N Tomes
Aug 1, 2012·Oncology Letters·Na HanLisong Teng
Jan 3, 2013·Journal of Thrombosis and Haemostasis : JTH·A FalangaA Vignoli
Feb 26, 2013·Nature Reviews. Immunology·Elzbieta Kolaczkowska, Paul Kubes
Nov 23, 2013·Nature Reviews. Cancer·Nicolas ReymondAnne J Ridley
Mar 13, 2014·Journal of Cellular Physiology·Soledad LangeGareth I Owen
Dec 4, 2014·Blood Reviews·Ewelina M Golebiewska, Alastair W Poole
Dec 19, 2014·Clinical Medicine Insights. Oncology·Ghaleb ElyamanyEman Bukhary
Dec 24, 2014·Indian Journal of Anaesthesia·Sanjeev PaltaAnshu Palta
Mar 10, 2015·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Cliona C KirwanG J Byrne
May 6, 2016·Frontiers in Oncology·Alessandro NatoniMichael E O'Dwyer
Nov 5, 2016·International Journal of Cancer. Journal International Du Cancer·Anna DeschStefan W Schneider
Nov 16, 2016·Cancer Cell·Yang Liu, Xuetao Cao
Dec 23, 2016·Journal of Cellular Physiology·Safieh EbrahimiSeyed Mahdi Hassanian
Dec 26, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ya-Min TangQiao-Li Liang
Feb 6, 2018·Cardiovascular Diagnosis and Therapy·Hassan AlbadawiRahmi Oklu

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
Fluorescence
flow cytometry
Assay
electrophoresis

Software Mentioned

- Quest
Bioconductor package oligo
Cell
ImageJ
R
Limma

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.